The Cigna Group FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $274.9B |
| Gross margin | 21.8% |
| Operating income | $9.2B |
| Net income | $6.0B |
| Diluted EPS | $22.18 |
| Cash & equivalents | $7.7B |
| Total assets | $157.9B |
| Long-term debt | $30.9B |
Key takeaway
Cigna completed the sale of its Medicare Advantage, Medicare Part D, Medicare Supplemental Benefits, and CareAllies businesses to Health Care Service Corporation on March 19, 2025, reshaping the U.S. Healthcare segment's mix.
🔒 4 more takeaways in the full analysis
Beneath the surface
Net debt is understated by headline figures alone: total debt (long-term debt of $30.87B plus current debt of $592M) against cash of $7.68B implies a substantial net debt position of roughly $23.8B, not obvious from the cash figure alone.
🔒 4 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 8 more findings — plus insider trades, activist stakes, and 8-K events for CI.
Read the full analysis free Free account · 5 full analyses included · no card required